Phase
Condition
Covid-19
Treatment
pulmonary vascular dysfunction
pulmonary vascular function
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age ≥ 18 years, patients with a suspected diagnosis of post/long-COVID-19 syndromewho present to our pneumology or infectious disease outpatient clinic orcorresponding ward from the start of the study and whose SARS-CoV-2 infection wasdiagnosed at least 3 and not longer than 18 months prior to presentation
Patients at least 3 and not longer than 18 months after a SARS-CoV-2 infectionwithout post/long-COVID-19 syndrome who present to our post-infection outpatientclinic for follow-up
Exclusion
Exclusion Criteria:
Patients who refuse to participate in the study
Severe underlying chronic pulmonary, cardiac, or systemic disease (e.g., Chronicobstructive pulmonary disease (COPD), severe heart failure, neuromuscular disease)that was diagnosed prior to acute COVID-19 disease and whose progression appearslikely as the cause of dyspnea
Other non pneumologic causes of dyspnea (e.g., hemoglobin < 100 g/L)
Unstable or acute disease (e.g., acute infection, acute renal failure, acutecoronary syndrome)
Inability to perform spiroergometry, including transient orthopedic problems,contraindications to central venous and arterial catheter placement (e.g., severebleeding tendency).
Study Design
Study Description
Connect with a study center
Natascha Sommer
Giessen,
GermanySite Not Available
Natascha Sommer
Giessen 2920512,
GermanySite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.